Physician profile
Lisa Schultz
NPI 1073192340
$760.93
in general payments reported to CMS, 2019-2025
11 companies · $62.41 in 2025
The $62.41 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.83 · 2022: $142 · 2023: $181 · 2024: $298 · 2025: $62.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $342.35 | 2023-2024 | Qelbree, Qelbree |
| Corium, LLC | $120.62 | 2021-2025 | Azstarys |
| Glaxosmithkline, LLC. | $74.34 | 2022-2025 | Bexsero |
| Ironshore Pharmaceuticals INC. | $47.56 | 2022 | |
| Cranial Technologies, INC | $42.43 | 2021-2022 | |
| Adlon Therapeutics L.P. | $29.77 | 2021 | |
| Merck Sharp & Dohme LLC | $28.28 | 2023-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Hollister Incorporated | $21.03 | 2025 | Adapt Ceraring, New Image |
| Takeda Pharmaceuticals U.S.A., INC. | $20.87 | 2022 | |
| Vertical Pharmaceuticals, LLC | $19.74 | 2024 | Relexxii |
| Cognoa, INC. | $13.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.